Companies › Brainfarma Industria Química e Farmacêutica S/A
2 active drug programs in 10 registered trials: 5 Phase 4, 3 Phase 3, 2 Phase 2; Neurology, Cardiovascular, Metabolic and endocrine, Oncology; next expected readout Jun 2027.
Open in Phaseline: competitors, likelihood bands and readouts Company report
| Drug | Target | Highest phase | Conditions | Next expected readout |
|---|---|---|---|---|
| Pregabalin Voltage-gated calcium channel modulator | Ion channels, CACNB4, CACNB2, CACNB1, CACNB3 | Phase 3 | Diabetic Neuropathy; Shoulder Arthropathy; Pregabalin; Diabetic Pruritus … | Jun 2027 |
| Dipyrone Cyclooxygenase inhibitor | PTGS2, PTGS1 | Phase 3 | Common Cold/Flu; Hematologic Test | Jun 2027 |
| Registry id | Drug | Phase | Conditions | Area | Expected readout |
|---|---|---|---|---|---|
| NCT05488847 | Pregabalin | Phase 4 | Shoulder Arthropathy | Other | Dec 2024 |
| NCT05640453 | Pregabalin | Phase 4 | Pregabalin | Cardiovascular | May 2026 |
| NCT06790537 | Pregabalin | Phase 4 | Diabetic Pruritus | Metabolic and endocrine | Jun 2026 |
| NCT06150898 | Pregabalin | Phase 2 | Early-stage Breast Cancer | Oncology | Apr 2027 |
| NCT07712913 | Pregabalin | Phase 3 | Diabetic Neuropathy | Neurology | Jun 2027 |
| NCT07626437 | Dipyrone | Phase 3 | Common Cold/Flu | Infectious disease | Jun 2027 |
| NCT07626437 | Dipyrone | Phase 3 | Common Cold/Flu | Infectious disease | Jun 2027 |
| NCT07918040 | Dipyrone | Phase 4 | Hematologic Test | Hematology | Jul 2027 |
| NCT06614322 | Pregabalin | Phase 2 | Painful Peripheral Neuropathy | Neurology | Jun 2028 |
| NCT07076069 | Pregabalin | Phase 4 | Rotator Cuff Repairs | Other | Jun 2028 |
Laboratorios Silanes S.A. de C.V. Tiohundra Laboratorio Elea Phoenix Soleno Therapeutics Shenzhen Ausa Pharmed
Pipelines of the same shape: areas, drug types, target families, stage and cash runway.
Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.